NASDAQ:LIAN LianBio (LIAN) Stock Price, News & Analysis $0.06 +0.01 (+14.33%) As of 10/2/2026 Add Compare Share Share Stock Analysis Stock AnalysisChartCompetitorsFDA EventsSEC Filings About LianBio Stock (NASDAQ:LIAN) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get LianBio alerts:Sign Up Key Stats Today's Range$0.05▼$0.0650-Day Range$0.03▼$0.0652-Week Range$0.27▼$4.99Volume321 shsAverage Volume1.04 million shsMarket Capitalization$6.29 millionP/E RatioN/ADividend YieldN/APrice TargetN/AConsensus RatingN/A Company Overview LianBio was a clinical-stage biopharmaceutical company focused on developing and commercializing innovative medicines in China and other key Asian markets. The company’s business model centered on partnering with biotechnology and pharmaceutical companies to obtain regional rights to promising therapies and advance them through clinical development, regulatory review and potential commercialization. LianBio’s activities historically spanned several therapeutic areas, including cardiovascular disease, oncology, immunology and other serious conditions with significant unmet medical needs. Its pipeline included internally and partner-developed programs, with development strategies tailored to patients and regulatory requirements in Greater China and selected Asia-Pacific markets. Founded in 2019 with backing from Perceptive Advisors, LianBio was headquartered in Shanghai and operated as a cross-border drug-development platform. Dr. Carsten Brunn served as the company’s president and chief executive officer during its public-company period. LianBio later undertook a strategic restructuring and ceased operating as a publicly traded company, making its historical business and pipeline the primary context for the NASDAQ: LIAN listing.AI Generated. May Contain Errors. Read More Receive LIAN Stock News and Ratings via Email Sign-up to receive the latest news and ratings for LianBio and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. LIAN Stock News HeadlinesLianMedical (Formerly Known as LianBio) Announces Completion of Merger Between LianBio and LianMedicalJuly 17, 2026 | finance.yahoo.comMeiraGTx Holdings PLCMay 3, 2025 | marketwatch.comTrump's New DollarPorter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening. The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result.October 4 at 1:00 AM | Porter & Company (Ad)China's Zeekr prices US IPO at top of range to raise $441 millionMay 10, 2024 | msn.comExclusive-China's Zeekr prices US IPO at top of range to raise $441 million, source saysMay 9, 2024 | msn.comLianBio Announces Wind Down Of Operations, Workforce Reduction; Stock Up In Pre-MarketFebruary 13, 2024 | markets.businessinsider.comLianBio to Wind Down Operations, Declares Special DividendFebruary 13, 2024 | marketwatch.comLianBio Shares Gain After Co Announces Plans to Wind DownFebruary 13, 2024 | marketwatch.comSee More Headlines LIAN Stock Analysis - Frequently Asked Questions How have LIAN shares performed this year? LianBio's stock was trading at $0.0950 on January 1st, 2026. Since then, LIAN shares have decreased by 38.7% and is now trading at $0.0583. How were LianBio's earnings last quarter? LianBio (NASDAQ:LIAN) released its earnings results on Monday, March, 27th. The company reported ($0.17) EPS for the quarter, topping analysts' consensus estimates of ($0.27) by $0.10. When did LianBio IPO? LianBio (LIAN) raised $325 million in an initial public offering on the week of November 1st 2021. The company issued 20,300,000 shares at a price of $16.00 per share. Goldman Sachs, Jefferies and BofA Securities served as the underwriters for the IPO. How do I buy shares of LianBio? Shares of LIAN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of LianBio own? Based on aggregate information from My MarketBeat watchlists, some other companies that LianBio investors own include Arista Networks (ANET), NVIDIA (NVDA), ServiceNow (NOW), Broadcom (AVGO), Novo Nordisk A/S (NVO), PACCAR (PCAR) and Super Micro Computer (SMCI). Company Calendar Last Earnings3/27/2023Today10/04/2026Fiscal Year End12/31/2026Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Pharmaceuticals Sub-IndustryPharmaceuticals Current SymbolNASDAQ:LIAN CIK1831283 Webwww.lianbio.com Phone609-486-2308FaxN/AEmployees110Year Founded2019Profitability EPS (Trailing Twelve Months)($0.81) Trailing P/E RatioN/A Forward P/E Ratio0.02 P/E GrowthN/ANet Income-$110.29 million Net MarginsN/A Pretax MarginN/A Return on Equity-33.17% Return on Assets-30.19% Debt Debt-to-Equity RatioN/A Current Ratio10.06 Quick Ratio10.06 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value$2.71 per share Price / Book0.02Miscellaneous Outstanding Shares108,063,000Free Float99,861,000Market Cap$6.29 million OptionableNot Optionable Beta0.23 Social Links Options Trading Made Easy - Download NowLearn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.Get This Free Report This page (NASDAQ:LIAN) was last updated on 10/4/2026 by MarketBeat.com Staff. From Our PartnersElon Warns "America Will Go Bankrupt". Trump's Plan Inside.National debt just crossed 40 trillion dollars, and Elon Musk says America is 1,000% going to go bankrupt with...American Hartford Gold | SponsoredThese gold assets are priced for $1,800 gold [it's over $4,000]Gold's major miners are generating record free cash flow, with margins as high as 75 percent even after gold's...Golden Portfolio | SponsoredSmall Colorado Company (Backed by Sam Altman) Could Save U.S. Power GridA small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...Altimetry | SponsoredHow Elon’s Empire Ends (and how to profit)Marc Chaikin, the 60 year Wall Street veteran whose Chaikin Money Flow indicator sits on every Bloomberg termi...Chaikin Analytics | SponsoredYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. ...Profits Run | SponsoredTrump’s issues shocking Executive Order on U.S. DollarThree days into his second term, President Trump signed Executive Order 14178 a move the press barely covered....Banyan Hill Publishing | SponsoredWATCH THIS BEFORE DECEMBER 8th!!James Altucher says a quiet government filing could reveal Elon Musk's biggest move yet, and almost nobody has...Paradigm Press | SponsoredA new kind of civil war is coming after election day?Across America, AI-driven backlash is fueling protests, lawsuits, and moratoria that could reshape the politic...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding LianBio Please log in to your account or sign up in order to add this asset to your watchlist. Share LianBio With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free LIAN Stock Alerts